By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteomics reagents and biomarker firm Proteome Sciences today reported that its revenues for 2010 jumped more than seven-fold as a result of a large settlement with Sanofi-Aventis Deutschland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.